Singapore clears VUNO’s AI software program for fundus evaluation
South Korean medical AI agency VUNO has not too long ago obtained a medical gadget certification from Singapore’s Well being Sciences Authority for its AI-based fundus evaluation software program.
The VUNO Med-Fundus AI analyses photos of the fundus, which is the again a part of the attention, to offer findings essential for the prognosis of retinal ailments. It will probably detect the situation of lesions indicative of ailments, reminiscent of diabetic retinopathy, macular illness and glaucoma, inside seconds.
By way of this certification, VUNO can faucet into the rising medical gadgets market in Singapore, which is projected to achieve $1 billion in worth in 2024, rising at an 8.7% CAGR from 2019.
Taiwan-based Level Robotics will get 510(okay) for its surgical robotic system
Level Robotics, maker of surgical robots in Taiwan, has acquired the US Meals and Drug Administration’s 510(okay) clearance for its built-in robotic-assisted surgical system for spinal fusion surgical procedures.
The POINT Kinguide Robotic-Assisted Surgical System combines image-guided navigation and a hand-held drilling function to streamline procedural duties with precision, stability, and reproducibility of robotic movement.
What units it other than comparable methods, in keeping with the corporate, is the parallel manipulator mechanism that permits it to develop indications for extra difficult herniated disc decompression surgical procedure.
Following the US clearance, Level Robotics is getting ready for CE marking in Europe and registration in China, increasing its presence in worldwide markets.
“We intention to advertise availability and affordability of robotic’s adoption for spinal surgical procedure unaddressed by in the present day’s know-how to deal with extra sufferers who contracted a spectrum of spinal ailments,” mentioned CEO SC Juang.
Psychological well being startup Lissun receives $1M in pre-seed funding
Indian psychological well being platform Lissun has raised $1 million in a pre-seed funding spherical led by IvyCap Ventures. The spherical was additionally participated by We Founder Circle, Supermorpheous and different marquee angel buyers.
The startup employs a novel “B2H2C” strategy – it reaches shoppers by way of its partnerships with healthcare establishments – in providing its full-stack psychological well being answer. It has tie-ups with over 70 healthcare organisations in 17 cities in India.
Based mostly on a press assertion, Lissun’s know-how is utilized to high-stress use instances in six healthcare classes, reminiscent of infertility, rehabilitation, nephrology, and oncology, amongst others. “The actual fact that psychological and emotional points will be an underlying downside in lots of medical instances is what we have now recognized and are engaged on proactively,” defined co-founder Dr Krishna Veer Singh.
By way of its recent funding, Lissun goals to strengthen its know-how’s spine and additional develop it to offer a seamless person expertise. Furthermore, it plans to develop to 25 cities, in addition to cowl 5 extra therapeutic classes.
India to repurpose COVID-19 apps
The Indian authorities plans to repurpose its two most important cellular purposes for monitoring COVID-19 instances within the nation.
A information report cited Dr Ram Sewak Sharma, CEO of the Nationwide Well being Authority, as saying that they plan to reuse the contact tracing app Aarogya Setu as a nationwide well being app whereas the Covid Vaccine Clever Community (CoWIN) platform shall be repurposed for the nationwide immunisation programme and a well being administration data system for small medical doctors.
